Locally Advanced Cutaneous Melanoma
2 clinical trials · Condition
◉ Watch Locally Advanced Cutaneous Melanoma
| Record | Firm | Date |
|---|---|---|
| Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210) | Fred Hutchinson Cancer Center | 2022-06-09 |
| Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma (NCT04375527) | Jonsson Comprehensive Cancer Center | 2020-12-03 |
Track Locally Advanced Cutaneous Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.